Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| NRC | NASDAQ | NRC Health | $20.83 | -3.52% | 46K | $474.17M |
| HELP | NASDAQ | Cybin Inc. Common Stock | $7.11 | -1.93% | 1.2M | $472.32M |
| TLRY | NASDAQ | Tilray Brands, Inc. | $3.88 | -2.76% | 6.6M | $465.61M |
| IMMX | NASDAQ | Immix Biopharma, Inc. | $9.57 | +8.75% | 2.3M | $463.5M |
| AQST | NASDAQ | Aquestive Therapeutics, Inc. | $3.68 | -2.39% | 2.9M | $461.72M |
| VREX | NASDAQ | Varex Imaging Corporation | $10.92 | +1.87% | 476K | $459.73M |
| PRTA | NASDAQ | Prothena Corporation plc | $8.66 | +2.24% | 577K | $458.09M |
| OFIX | NASDAQ | Orthofix Medical Inc. | $11.29 | +3.11% | 239K | $454.74M |
| VALN | NASDAQ | Valneva SE | $4.78 | 0.00% | 6K | $453.26M |
| AURA | NASDAQ | Aura Biosciences, Inc. | $7.05 | -2.08% | 326K | $452.61M |
| VMD | NASDAQ | Viemed Healthcare, Inc. | $11.77 | +0.86% | 229K | $451.22M |
| KYTX | NASDAQ | Kyverna Therapeutics, Inc. | $7.41 | +1.65% | 851K | $450.49M |
| CBIO | NASDAQ | Crescent Biopharma, Inc. | $16.71 | +5.56% | 257K | $449.42M |
| CABA | NASDAQ | Cabaletta Bio, Inc. | $2.69 | -1.10% | 1.7M | $438.62M |
| SRTA | NASDAQ | Strata Critical Medical, Inc. | $5.42 | +2.65% | 1.1M | $436.09M |
| OVID | NASDAQ | Ovid Therapeutics Inc. | $2.33 | -2.92% | 985K | $434.87M |
| NNNN | NASDAQ | Anbio Biotechnology Class A Ordinary Shares | $9.90 | +1.64% | 15K | $434.52M |
| CLPT | NASDAQ | ClearPoint Neuro, Inc. | $14.12 | -2.55% | 467K | $423.45M |
| PRTC | NASDAQ | PureTech Health plc | $17.04 | +1.67% | 10K | $423.09M |
| PACB | NASDAQ | Pacific Biosciences of California, Inc. | $1.40 | +1.45% | 8.1M | $422.42M |
| DCTH | NASDAQ | Delcath Systems, Inc. | $12.87 | -1.08% | 299K | $421.85M |
| LRMR | NASDAQ | Larimar Therapeutics, Inc. | $4.00 | -0.25% | 1.2M | $415.53M |
| OCGN | NASDAQ | Ocugen, Inc. | $1.21 | -4.72% | 4.1M | $409.61M |
| KMDA | NASDAQ | Kamada Ltd. | $7.12 | -0.42% | 18K | $407.32M |
| PBYI | NASDAQ | Puma Biotechnology, Inc. | $8.53 | +1.55% | 206K | $406.18M |
| ASMB | NASDAQ | Assembly Biosciences, Inc. | $25.55 | +1.31% | 142K | $406.06M |
| BNTC | NASDAQ | Benitec Biopharma Inc. | $11.97 | -6.34% | 162K | $394.04M |
| EOLS | NASDAQ | Evolus, Inc. | $5.98 | -0.17% | 697K | $393.81M |
| SOPH | NASDAQ | SOPHiA GENETICS S.A. | $5.69 | -0.49% | 193K | $393.18M |
| TOIIW | NASDAQ | The Oncology Institute, Inc. | $0.04 | -9.22% | 2K | $388.9M |
| AUTL | NASDAQ | Autolus Therapeutics plc | $1.51 | +4.14% | 717K | $385.91M |
| AVIR | NASDAQ | Atea Pharmaceuticals, Inc. | $4.81 | -1.23% | 381K | $378.53M |
| CCCC | NASDAQ | C4 Therapeutics, Inc. | $3.40 | -6.85% | 2.6M | $375.93M |
| CGC | NASDAQ | Canopy Growth Corporation | $0.89 | -1.82% | 1.6M | $375.13M |
| CMPX | NASDAQ | Compass Therapeutics, Inc. | $2.33 | +0.87% | 1.6M | $372.78M |
| ENTA | NASDAQ | Enanta Pharmaceuticals, Inc. | $12.78 | -1.31% | 105K | $371.62M |
| LXEO | NASDAQ | Lexeo Therapeutics, Inc. Common Stock | $4.66 | -1.06% | 657K | $365.91M |
| XFOR | NASDAQ | X4 Pharmaceuticals, Inc. | $3.85 | -3.51% | 574K | $363.13M |
| DMAC | NASDAQ | DiaMedica Therapeutics Inc. | $6.79 | -0.44% | 177K | $362.9M |
| NEO | NASDAQ | NeoGenomics, Inc. | $13.89 | -2.46% | 2M | $361.73M |
| MOBI | NASDAQ | Mobia Medical, Inc. Common Stock | $10.85 | -1.90% | 39K | $360.75M |
| CUVL | NASDAQ | Clinuvel Pharmaceuticals Ltd. | – | – | 250 | $356.53M |
| STTK | NASDAQ | Shattuck Labs, Inc. | $6.81 | +0.59% | 1.5M | $355.92M |
| SCTX | NASDAQ | Scribe Therapeutics Inc. | $21.65 | +44.33% | 986K | $350.34M |
| UPB | NASDAQ | Upstream Bio, Inc. | $6.41 | +0.16% | 626K | $348.83M |
| RCKT | NASDAQ | Rocket Pharmaceuticals, Inc. | $3.19 | -2.74% | 1.2M | $348.33M |
| FENC | NASDAQ | Fennec Pharmaceuticals Inc. | $9.99 | -1.58% | 90K | $347.02M |
| ABEO | NASDAQ | Abeona Therapeutics Inc. | $6.05 | -5.17% | 1.2M | $344.82M |
| PALI | NASDAQ | Palisade Bio, Inc. | $1.95 | -3.47% | 2.3M | $338.48M |
| AKBA | NASDAQ | Akebia Therapeutics, Inc. | $1.41 | +1.81% | 1.5M | $327.27M |